Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
AbbVie NYSE:ABBV |
365,43 B | 2,49% | 4/6 | 24,20% | -28,26% | 22,70% | DOWN |
|
Amgen NasdaqGS:AMGN |
178,00 B | 7,37% | 3/6 | 2,54% | -1,38% | 6,88% | UP |
|
Gilead Sciences NasdaqGS:GILD |
163,41 B | 3,31% | 5/6 | 3,83% | -44,53% | 21,91% | UP |
|
Alexion Pharmaceuticals NasdaqGM:ALXN |
40,34 B | 0,00% | 4/4 | 0,00% | 0,00% | -100,00% | UP |
|
Alnylam Pharmaceuticals NasdaqGS:ALNY |
39,51 B | 46,06% | 4/6 | 50,23% | 14,37% | 50,28% | DOWN |
|
Biogen NasdaqGS:BIIB |
27,62 B | -10,35% | 1/6 | -1,92% | 6,98% | 14,40% | UP |
|
Incyte NasdaqGS:INCY |
19,36 B | 41,79% | 5/6 | 8,74% | 26,74% | 9,90% | UP |
|
Arrowhead Pharmaceuticals NasdaqGS:ARWR |
10,48 B | 48,13% | 5/6 | -45,97% | -3,24% | 17,63% | UP |
|
BioMarin Pharmaceutical NasdaqGS:BMRN |
10,45 B | 12,22% | 5/6 | 42,00% | 61,25% | 73,88% | DOWN |
|
Blueprint Medicines NasdaqGS:BPMC |
8,38 B | 45,26% | 4/6 | 42,18% | -48,48% | 0,64% | UP |
|
Cidara Therapeutics NasdaqCM:CDTX |
6,97 B | -59,17% | 2/6 | 0,00% | -652349,57% | -100,00% | UP |
|
Arena Pharmaceuticals NasdaqGM:ARNA |
6,17 B | 0,00% | 0,00% | 0,00% | 0,00% | UP | |
|
Amicus Therapeutics NasdaqGM:FOLD |
4,55 B | 19,97% | 5/6 | 59,76% | -43,60% | 0,07% | UP |
|
Travere Therapeutics NasdaqGM:TVTX |
4,08 B | 10,07% | 5/6 | 42,10% | -116,17% | 13,33% | UP |
|
ACADIA Pharmaceuticals NasdaqGS:ACAD |
3,76 B | 29,02% | 5/6 | 15,27% | -24,50% | 48,06% | DOWN |
|
ChemoCentryx NasdaqGS:CCXI |
3,74 B | 0,00% | 0/4 | 0,00% | 0,00% | -100,00% | UP |
|
CymaBay Therapeutics NasdaqGS:CBAY |
3,72 B | 0,00% | 1/4 | 0,00% | 0,00% | -100,00% | UP |
|
Catalyst Pharmaceuticals NasdaqCM:CPRX |
3,51 B | 40,93% | 5/6 | 5,58% | 11,98% | 21,78% | UP |
|
Viking Therapeutics NasdaqCM:VKTX |
3,48 B | 0,00% | 0/4 | 0,00% | 0,00% | 231,67% | DOWN |
|
Celldex Therapeutics NasdaqCM:CLDX |
2,54 B | -34,06% | 1/6 | 114,74% | -393,43% | 70,23% | UP |
